Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saurav Chatterjee

Showing results (111-120 of 194) with videos related to

Pageof 20
Sort By:
Plos One|November 9, 2013
New oral anticoagulants are not superior to warfarin in secondary prevention of stroke or transient ischemic attacks, but lower the risk of intracranial bleeding: insights from a meta-analysis and indirect treatment comparisonsPartha Sardar, Saurav Chatterjee, Wen-Chih Wu, et al.
The American Journal of Cardiology|August 14, 2014
Meta-analysis of left ventricular hypertrophy and sustained arrhythmiasSaurav Chatterjee, Chirag Bavishi, Partha Sardar, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 4, 2015
Outcomes After Cardioversion in Atrial Fibrillation Patients Treated with Non-Vitamin K Antagonist Oral Anticoagulants (NOACs): Insights from a Meta-AnalysisParijat Sen, Amartya Kundu, Partha Sardar, et al.
The American Journal of Cardiology|December 10, 2013
Meta-analysis of prognostic implications of dyspnea versus chest pain in patients referred for stress testingEdgar Argulian, Vikram Agarwal, Sripal Bangalore, et al.
JACC. Advances|September 20, 2025
Analysis of FDA-Approved Artificial Intelligence and Machine Learning-Enabled Cardiovascular DevicesPartha Sardar, Elena Dudorova, Saurav Chatterjee, et al.
International Journal of Cardiology|August 3, 2013
Clopidogrel is safer than ticagrelor in regard to bleeds: a closer look at the PLATO trialJames J DiNicolantonio, Fabrizio D'Ascenzo, Ales Tomek, et al.
Chest|June 1, 2013
Risk of serious atrial fibrillation and stroke with use of bisphosphonates: evidence from a meta-analysisAbhishek Sharma, Saurav Chatterjee, Armin Arbab-Zadeh, et al.
Chemical Science|August 15, 2024
Harnessing a bis-electrophilic boronic acid lynchpin for azaborolo thiazolidine (ABT) grafting in cyclic peptidesBasab Kanti Das, Arnab Chowdhury, Saurav Chatterjee, et al.
Bioorganic & Medicinal Chemistry Letters|February 27, 2018
Synthesis and biological evaluation of polyhydroxylated oxindole derivatives as potential antileishmanial agentMd Yousuf, Debarati Mukherjee, Somaditya Dey, et al.
Current Cardiology Reports|February 14, 2018
Therapeutic Options for In-Stent RestenosisCharles Nicolais, Vladimir Lakhter, Hafeez Ul Hassan Virk, et al.
Pageof 20

Showing results (111-120 of 194) with videos related to

Sort By:
Pageof 20
Plos One|November 9, 2013
New oral anticoagulants are not superior to warfarin in secondary prevention of stroke or transient ischemic attacks, but lower the risk of intracranial bleeding: insights from a meta-analysis and indirect treatment comparisonsPartha Sardar, Saurav Chatterjee, Wen-Chih Wu, et al.
The American Journal of Cardiology|August 14, 2014
Meta-analysis of left ventricular hypertrophy and sustained arrhythmiasSaurav Chatterjee, Chirag Bavishi, Partha Sardar, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 4, 2015
Outcomes After Cardioversion in Atrial Fibrillation Patients Treated with Non-Vitamin K Antagonist Oral Anticoagulants (NOACs): Insights from a Meta-AnalysisParijat Sen, Amartya Kundu, Partha Sardar, et al.
The American Journal of Cardiology|December 10, 2013
Meta-analysis of prognostic implications of dyspnea versus chest pain in patients referred for stress testingEdgar Argulian, Vikram Agarwal, Sripal Bangalore, et al.
JACC. Advances|September 20, 2025
Analysis of FDA-Approved Artificial Intelligence and Machine Learning-Enabled Cardiovascular DevicesPartha Sardar, Elena Dudorova, Saurav Chatterjee, et al.
International Journal of Cardiology|August 3, 2013
Clopidogrel is safer than ticagrelor in regard to bleeds: a closer look at the PLATO trialJames J DiNicolantonio, Fabrizio D'Ascenzo, Ales Tomek, et al.
Chest|June 1, 2013
Risk of serious atrial fibrillation and stroke with use of bisphosphonates: evidence from a meta-analysisAbhishek Sharma, Saurav Chatterjee, Armin Arbab-Zadeh, et al.
Chemical Science|August 15, 2024
Harnessing a bis-electrophilic boronic acid lynchpin for azaborolo thiazolidine (ABT) grafting in cyclic peptidesBasab Kanti Das, Arnab Chowdhury, Saurav Chatterjee, et al.
Bioorganic & Medicinal Chemistry Letters|February 27, 2018
Synthesis and biological evaluation of polyhydroxylated oxindole derivatives as potential antileishmanial agentMd Yousuf, Debarati Mukherjee, Somaditya Dey, et al.
Current Cardiology Reports|February 14, 2018
Therapeutic Options for In-Stent RestenosisCharles Nicolais, Vladimir Lakhter, Hafeez Ul Hassan Virk, et al.
Pageof 20